Bill > S207

This bill, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act of 2017, amends the Controlled Substances Act to provide a list of factors that may be considered as evidence to determine whether a controlled substance analogue, which is a drug, substance, or chemical that is similar to a controlled substance, is intended for human consumption. These factors include the marketing, advertising, and labeling of the substance, its known efficacy or usefulness, the price difference compared to the substance it is meant to mimic, the diversion of the substance from legitimate channels, and whether the defendant knew or should have known the substance was intended for immediate use. The bill also clarifies that the existence of evidence that a substance was not marketed, advertised, or labeled for human consumption does not preclude the government from establishing that it was intended for human consumption based on all the available evidence.

Justice

https://www.congress.gov/bill/115th-congress/senate-bill/207/all-info